FNY Investment Advisers LLC purchased a new stake in Corcept Therapeutics Incorporated (NASDAQ:CORT – Free Report) in the fourth quarter, Holdings Channel reports. The institutional investor purchased 1,000 shares of the biotechnology company’s stock, valued at approximately $32,000. Several other large investors have also bought and sold shares of the stock. Linden Thomas Advisory Services […]
Mutual Advisors LLC Takes Position in Corcept Therapeutics Incorporated (NASDAQ:CORT) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
WILMINGTON, Del., Feb. 29, 2024 Prelude Therapeutics Incorporated , a clinical-stage precision oncology company, announced today that the Company will participate in the Barclays Global.
Prelude Therapeutics to Participate in Barclays Global Healthcare Conference tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.
StockNews.com upgraded shares of Corcept Therapeutics (NASDAQ:CORT – Free Report) from a buy rating to a strong-buy rating in a research note published on Saturday morning. Several other equities research analysts have also commented on the stock. Truist Financial lifted their price target on shares of Corcept Therapeutics from $36.00 to $42.00 and gave the […]